|
|
|
0 members (),
884
guests, and
22
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
|
|
|
|
1
|
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
|
30
|
|
|
|
|
|
|
|
There are no members with birthdays on this day. |
#328450
Wed 02 Sep 2015 11:13:PM
|
Joined: Feb 2001
Posts: 381,904
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,904 |
Imetelstat, a novel drug that targets telomerase, has demonstrated potential value in treating patients with myelofibrosis, according to the results of a new study. Source: Telomerase targeting drug demonstrates benefit in myelofibrosis treatment
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Entire Thread
|
Telomerase targeting drug demonstrates benefit in myelofibrosis treatment
|
Webmaster
|
Wed 02 Sep 2015 11:13:PM
|
|
Forums60
Topics748,108
Posts782,770
Members2,958
| |
Most Online4,158
Jun 21st, 2024
|
|
|
|
|
Copyright 1996 - 2024 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under the agreement, to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and e-mail lists of AUS-CITY are distributed with permission from DoD/USSTRATCOM.
Reprise Hosting
|
|
